Morningstar (MORN) is back in focus after reporting first quarter results that showed 10.8% year on year revenue growth and operating income up more than 30%, comfortably ahead of analyst expectations.

Morningstar’s strong first quarter and recent product launches in credit analytics and AI enabled data access have coincided with a 10.25% 90 day share price return. However, the year to date share price is still down 14.63% and the 1 year total shareholder return is down 40.41%, pointing to improving short term momentum after a weak longer stretch.

If you are reassessing data and analytics stocks after Morningstar’s move, this can be a good moment to widen the search and check out 20 top founder-led companies

So with Morningstar stock still down sharply over 1 year, even after a strong quarter, a 40% discount to analyst price targets and mixed value scores, are you looking at an underappreciated recovery story, or a market that already sees the growth ahead?

Preferred P/E of 17x: Is it justified?

On a P/E of 17x, Morningstar trades below both the US Capital Markets industry average of 39.9x and a peer average of 24.1x, even after the recent rebound in the share price.

The P/E multiple compares the current share price to the company’s earnings per share and is a quick way for you to see how much the market is paying for each dollar of profit. For a data and analytics provider with established franchises like Morningstar Direct, PitchBook and Credit, this benchmark often feeds directly into how investors think about the durability and quality of those earnings.

Here, the market is assigning a lower P/E than both industry and peer groups, which points to more conservative expectations around future earnings than the sector overall. At the same time, the SWS fair P/E estimate of 14.3x sits under the current 17x level, suggesting some of that relative discount could narrow if the valuation multiple were to move closer to the fair ratio implied by the model.

Result: Price-to-earnings of 17x (ABOUT RIGHT)

However, there are still clear risks, including extended share price weakness over 1 and 5 years and the possibility that analyst price targets remain too optimistic.

Another View: Our DCF Model Says the Stock Is Expensive

The P/E comparison points to Morningstar trading around fair value, but the SWS DCF model tells a different story. On that measure, the stock at $179.64 sits above an estimated future cash flow value of $135.45, which frames today’s price as overvalued rather than discounted.

For a stock that screens as both cheaper than peers on P/E and expensive versus our DCF, it comes down to which signal you trust more: earnings today or the cash flows projected tomorrow?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Morningstar for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With a mixed picture of risks and potential rewards, this is a moment to move quickly, explore the numbers for yourself, and decide where you stand based on the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If Morningstar has sharpened your thinking, do not stop there. Widen your watchlist now or you risk missing other opportunities setting up beneath the surface.

• Target high quality companies that might be temporarily overlooked by checking out the 48 high quality undervalued stocks.
• Lock in potential income opportunities by reviewing the 10 dividend fortresses built for investors who care about yield and resilience.
• Focus on strength and staying power by scanning the solid balance sheet and fundamentals stocks screener (46 results) that filters for sturdier financial foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.